Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.
Report ID | 220261 |
Drug Identification Number | 02173360 |
Brand name | TEVA-SALBUTAMOL STERINEBS P.F. |
Common or Proper name | TEVA-SALBUTAMOL 2MG/ML NEBS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SALBUTAMOL |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 20x2.5ml |
ATC code | R03AC |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-20 |
Estimated end date | 2024-09-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-03-14 | French | Compare |
v3 | 2024-03-14 | English | Compare |
v2 | 2024-02-22 | French | Compare |
v1 | 2024-02-22 | English | Compare |
Showing 1 to 4 of 4